IP Verse

Tron Translationale Onkologie An Der Universittsmedizin Der Johannes Gutenberg Universitt Mainz Gemeinntzige competitive analysis

Latest publications and patents of Tron Translationale Onkologie An Der Universittsmedizin Der Johannes Gutenberg Universitt Mainz Gemeinntzige New

Explore the latest publications and patents granted to Tron Translationale Onkologie An Der Universittsmedizin Der Johannes Gutenberg Universitt Mainz Gemeinntzige, showcasing their recent innovations and technological advancements.

Last updated on: Sep 18, 2025

Publication Number	Publication Date	Title	Legal Status
Get instant update for new patents of Tron Translationale Onkologie An Der Universittsmedizin Der Johannes Gutenberg Universitt Mainz Gemeinntzige
EP3791896	Jan 10, 2024	Combination Therapy Involving Antibodies Against Claudin 18.2 For Treatment Of Cancer	Granted And Under Opposition
EP3294325	Jul 26, 2023	Enhancing The Effect Of Car-Engineered T Cells By Means Of Nucleic Acid Vaccination	Granted And Under Opposition
EP3892295	Apr 26, 2023	Individualized Vaccines For Cancer	Granted And Under Opposition
EP3725810	Jul 6, 2022	Combination Therapy Involving Antibodies Against Claudin 18.2 For Treatment Of Cancer	Revoked
EP3126381	Feb 16, 2022	Claudin-6-Specific Immunoreceptors And T Cell Epitopes	Patent Maintained As Amended
EP3473267	Sep 8, 2021	Individualized Vaccines For Cancer	Granted And Under Opposition
EP3254695	Sep 9, 2020	Combination Therapy Involving Antibodies Against Claudin 18.2 For Treatment Of Cancer	Granted And Under Opposition
EP3294333	Sep 2, 2020	Claudin-18.2-Specific Immunoreceptors And T Cell Epitopes	Granted And Under Opposition
EP2714071	Jul 10, 2019	Individualized Vaccines For Cancer	Opposition Rejected
EP2125897	Jan 17, 2018	Monoclonal Antibodies For Treatment Of Cancer	No Opposition Filed Within Time Limit

Latest patents of Tron Translationale Onkologie An Der Universittsmedizin Der Johannes Gutenberg Universitt Mainz Gemeinntzige opposed by its competitors

Explore Tron Translationale Onkologie An Der Universittsmedizin Der Johannes Gutenberg Universitt Mainz Gemeinntzige's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 25, 2025

Patent Number	Grant Date	Title	Total Oppositions
EP3791896	Jan 10, 2024	Combination Therapy Involving Antibodies Against Claudin 18.2 For Treatment Of Cancer	3
EP3294325	Jul 26, 2023	Enhancing The Effect Of Car-Engineered T Cells By Means Of Nucleic Acid Vaccination	1
EP3892295	Apr 26, 2023	Individualized Vaccines For Cancer	1
EP3725810	Jul 6, 2022	Combination Therapy Involving Antibodies Against Claudin 18.2 For Treatment Of Cancer	2
EP3126381	Feb 16, 2022	Claudin-6-Specific Immunoreceptors And T Cell Epitopes	1
EP3473267	Sep 8, 2021	Individualized Vaccines For Cancer	1
EP3254695	Sep 9, 2020	Combination Therapy Involving Antibodies Against Claudin 18.2 For Treatment Of Cancer	1
EP3294333	Sep 2, 2020	Claudin-18.2-Specific Immunoreceptors And T Cell Epitopes	1
EP2714071	Jul 10, 2019	Individualized Vaccines For Cancer	3

Latest PTAB cases involving Tron Translationale Onkologie An Der Universittsmedizin Der Johannes Gutenberg Universitt Mainz Gemeinntzige

Discover the latest PTAB cases involving Tron Translationale Onkologie An Der Universittsmedizin Der Johannes Gutenberg Universitt Mainz Gemeinntzige, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Tron Translationale Onkologie An Der Universittsmedizin Der Johannes Gutenberg Universitt Mainz Gemeinntzige with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 25, 2025

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced	Strategy Type
TRON TRANSLATIONALE ONKOLOGIE AN DER UNIVERSITTSMEDIZIN DER JOHANNES GUTENBERG UNIVERSITT MAINZ GEMEINNTZIGE	-	14	-	-	Non-Active
DR H ULRICH DORRIES	26	-	-	-	Highly Aggressive
MAIWALD	132	-	-	-	Highly Aggressive
WITHERS & ROGERS	33	-	-	-	Highly Aggressive